ICU Medical Operating Margin 2010-2024 | ICUI
Current and historical operating margin for ICU Medical (ICUI) over the last 10 years. The current operating profit margin for ICU Medical as of March 31, 2024 is 5.01%.
| ICU Medical Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-03-31 | $2.26B | $0.00B | 0.13% |
| 2023-12-31 | $2.26B | $0.02B | 1.02% |
| 2023-09-30 | $2.25B | $0.04B | 1.56% |
| 2023-06-30 | $2.29B | $0.01B | 0.52% |
| 2023-03-31 | $2.31B | $0.01B | 0.39% |
| 2022-12-31 | $2.28B | $-0.04B | -1.84% |
| 2022-09-30 | $2.04B | $-0.02B | -0.88% |
| 2022-06-30 | $1.78B | $0.02B | 1.12% |
| 2022-03-31 | $1.54B | $0.05B | 3.50% |
| 2021-12-31 | $1.32B | $0.12B | 9.34% |
| 2021-09-30 | $1.30B | $0.13B | 9.72% |
| 2021-06-30 | $1.28B | $0.11B | 8.91% |
| 2021-03-31 | $1.26B | $0.10B | 7.94% |
| 2020-12-31 | $1.27B | $0.10B | 7.79% |
| 2020-09-30 | $1.27B | $0.09B | 7.10% |
| 2020-06-30 | $1.26B | $0.10B | 7.73% |
| 2020-03-31 | $1.26B | $0.10B | 8.15% |
| 2019-12-31 | $1.27B | $0.11B | 8.45% |
| 2019-09-30 | $1.29B | $0.08B | 6.20% |
| 2019-06-30 | $1.31B | $0.05B | 3.74% |
| 2019-03-31 | $1.36B | $0.06B | 4.05% |
| 2018-12-31 | $1.40B | $0.03B | 2.14% |
| 2018-09-30 | $1.43B | $0.08B | 5.74% |
| 2018-06-30 | $1.45B | $0.08B | 5.26% |
| 2018-03-31 | $1.42B | $0.01B | 0.56% |
| 2017-12-31 | $1.29B | $-0.01B | -1.08% |
| 2017-09-30 | $1.02B | $-0.04B | -4.22% |
| 2017-06-30 | $0.77B | $-0.02B | -2.20% |
| 2017-03-31 | $0.54B | $0.04B | 7.81% |
| 2016-12-31 | $0.38B | $0.08B | 21.84% |
| 2016-09-30 | $0.37B | $0.08B | 21.93% |
| 2016-06-30 | $0.36B | $0.09B | 23.42% |
| 2016-03-31 | $0.35B | $0.08B | 23.43% |
| 2015-12-31 | $0.34B | $0.07B | 20.23% |
| 2015-09-30 | $0.33B | $0.07B | 20.54% |
| 2015-06-30 | $0.32B | $0.05B | 15.84% |
| 2015-03-31 | $0.32B | $0.04B | 12.62% |
| 2014-12-31 | $0.31B | $0.04B | 12.62% |
| 2014-09-30 | $0.31B | $0.04B | 13.36% |
| 2014-06-30 | $0.31B | $0.05B | 15.34% |
| 2014-03-31 | $0.31B | $0.05B | 15.97% |
| 2013-12-31 | $0.31B | $0.05B | 16.56% |
| 2013-09-30 | $0.32B | $0.06B | 17.87% |
| 2013-06-30 | $0.32B | $0.06B | 18.93% |
| 2013-03-31 | $0.32B | $0.06B | 20.00% |
| 2012-12-31 | $0.32B | $0.06B | 19.56% |
| 2012-09-30 | $0.31B | $0.07B | 22.26% |
| 2012-06-30 | $0.31B | $0.06B | 20.98% |
| 2012-03-31 | $0.31B | $0.06B | 20.92% |
| 2011-12-31 | $0.30B | $0.07B | 21.59% |
| 2011-09-30 | $0.30B | $0.05B | 18.06% |
| 2011-06-30 | $0.30B | $0.06B | 18.73% |
| 2011-03-31 | $0.29B | $0.05B | 18.62% |
| 2010-12-31 | $0.28B | $0.05B | 16.96% |
| 2010-09-30 | $0.28B | $0.04B | 14.86% |
| 2010-06-30 | $0.25B | $0.03B | 13.39% |
| 2010-03-31 | $0.24B | $0.03B | 13.03% |
| 2009-12-31 | $0.23B | $0.04B | 15.79% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.875B | $2.259B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.017B | 23.31 |
| Stryker (SYK) | United States | $126.483B | 30.29 |
| Boston Scientific (BSX) | United States | $111.661B | 35.56 |
| EssilorLuxottica (ESLOY) | France | $99.732B | 0.00 |
| Medtronic (MDT) | Ireland | $98.953B | 14.81 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.070B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.630B | 28.20 |
| ResMed (RMD) | United States | $27.824B | 26.12 |
| Terumo (TRUMY) | Japan | $24.790B | 35.01 |
| Koninklijke Philips (PHG) | Netherlands | $23.594B | 18.73 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.927B | 14.01 |
| Baxter (BAX) | United States | $16.898B | 12.01 |
| Insulet (PODD) | United States | $13.778B | 61.09 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.986B | 0.00 |
| Demant (WILYY) | Denmark | $9.175B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.709B | 36.26 |
| Bio-Rad Laboratories (BIO) | United States | $7.704B | 25.19 |
| Lantheus Holdings (LNTH) | United States | $5.515B | 13.74 |
| Haemonetics (HAE) | United States | $4.287B | 21.14 |
| GN Store Nord (GNNDY) | Denmark | $4.205B | 23.62 |
| Perrigo (PRGO) | Ireland | $3.570B | 10.82 |
| Prestige Consumer Healthcare (PBH) | United States | $3.360B | 15.99 |
| Neogen (NEOG) | United States | $3.295B | 31.69 |
| TG Therapeutics (TGTX) | United States | $2.904B | 81.70 |
| Envista Holdings (NVST) | United States | $2.800B | 11.55 |
| Green Thumb Industries (GTBIF) | United States | $2.467B | 48.29 |
| Agios Pharmaceuticals (AGIO) | United States | $2.386B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.077B | 11.53 |
| LeMaitre Vascular (LMAT) | United States | $1.825B | 53.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.761B | 0.00 |
| Warby Parker (WRBY) | United States | $1.609B | 0.00 |
| InMode (INMD) | Israel | $1.468B | 7.80 |
| Verano Holdings (VRNOF) | United States | $1.292B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.292B | 9.60 |
| AtriCure (ATRC) | United States | $1.068B | 0.00 |
| Owens & Minor (OMI) | United States | $1.003B | 8.74 |
| National Vision Holdings (EYE) | United States | $0.977B | 31.08 |
| BioLife Solutions (BLFS) | United States | $0.923B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.791B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.694B | 14.78 |
| Evolus (EOLS) | United States | $0.688B | 0.00 |
| PetIQ (PETQ) | United States | $0.672B | 21.73 |
| Surmodics (SRDX) | United States | $0.599B | 37.48 |
| VAREX IMAGING (VREX) | United States | $0.587B | 13.81 |
| ZimVie (ZIMV) | United States | $0.506B | 43.16 |
| Valneva SE (VALN) | France | $0.501B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.495B | 0.00 |
| Quanterix (QTRX) | United States | $0.479B | 0.00 |
| Biote (BTMD) | United States | $0.459B | 10.57 |
| Jin Medical (ZJYL) | China | $0.438B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.394B | 0.00 |
| Cerus (CERS) | United States | $0.318B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.298B | 9.60 |
| Zynex (ZYXI) | United States | $0.283B | 38.78 |
| Aurora Cannabis (ACB) | Canada | $0.267B | 0.00 |
| MacroGenics (MGNX) | United States | $0.263B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.256B | 25.39 |
| Sanara MedTech (SMTI) | United States | $0.238B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.234B | 14.75 |
| Omeros (OMER) | United States | $0.225B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.220B | 0.00 |
| High Tide (HITI) | Canada | $0.171B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.165B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.154B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 19.89 |
| Veru (VERU) | United States | $0.134B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.102B | 10.29 |
| Brainsway (BWAY) | Israel | $0.099B | 0.00 |
| InterCure (INCR) | Israel | $0.097B | 16.31 |
| Cellectar Biosciences (CLRB) | United States | $0.089B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.071B | 4.66 |
| MariMed (MRMD) | United States | $0.071B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.054B | 0.00 |
| Bright Green (BGXX) | United States | $0.050B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.044B | 15.97 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Exagen (XGN) | United States | $0.031B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| Agape ATP (ATPC) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |